Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Assay Validation (Educational Session)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Exploiting the Success and Failure of Cancer Therapies: Investing Now in Accurate Biomarker Data to Improve Outcomes Later
Peter S. Nelson, M.D.
Fred Hutchinson Cancer Research Ctr., Seattle, WA
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 12:00 PM-2:00 PM
Biomarker Validation: Pre-analytic and Assay Performance
Dr. Andrew Hruszkewycz
National Cancer Institute, Rockville, MD
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 12:00 PM-2:00 PM
Accurate, Reproducible, and Quantitative Measurement of Protein Analyte Concentration(s) in Tissue Slides
David L. Rimm, M.D., Ph.D.
Yale Univ. School of Medicine, New Haven, CT
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 12:00 PM-2:00 PM
Statistical Issues in Biomarker Assay Development and Evaluation
Viswanath Devanarayan, Ph.D.
Abbott Laboratories, Parsippany NJ
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 12:00 PM-2:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4